JOAN SMITH: Open Payments
NPI 1407844129 · RED OAK, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$521 in 29 payments from 13 companies in 2025. Trend: 2023 $731 · 2024 $626 · 2025 $521
Food & beverage: $521
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $141 |
| Novartis Pharmaceuticals Corporation | 4 | $78 |
| Novo Nordisk Inc | 4 | $72 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Actelion Pharmaceuticals US, Inc. | 1 | $30 |
| Lundbeck LLC | 1 | $27 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| ABBVIE INC. | 1 | $24 |
| Baxter Healthcare | 1 | $24 |
| Insulet Corporation | 1 | $20 |
Products named: MOUNJARO, LEQVIO, Ozempic, JARDIANCE, CAMZYOS, OPSUMIT, REXULTI, INSPIRE.
Industry payments across IA — which companies pay providers there.
